Related references
Note: Only part of the references are listed.Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination
Federico Perez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Clonal Dissemination of Klebsiella pneumoniae Carbapenemase KPC-3 in Long Beach, California
Jennifer Le et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2010)
Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
Brandon Kitchel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Infection with Panresistant Klebsiella pneumoniae: A Report of 2 Cases and a Brief Review of the Literature
Azza Elemam et al.
CLINICAL INFECTIOUS DISEASES (2009)
Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae
Sandeep Kochar et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Pharmacokinetic Considerations regarding Tigecycline for Multidrug-Resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii Urosepsis
Burke A. Cunha
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann et al.
LANCET INFECTIOUS DISEASES (2009)
Streptococcus pneumoniae Coinfection Is Correlated with the Severity of H1N1 Pandemic Influenza
Gustavo Palacios et al.
PLOS ONE (2009)
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
Theodoros Kelesidis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
Krasimir Vasilev et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumanni
Marc H. Scheetz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Kenneth N. Agwuh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Share Paper
